Every US company we alert on
5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.
Sector
| # | Company | Sector | Market cap | Alerts | Latest |
|---|---|---|---|---|---|
| 7 | ELI Lilly & CoNYSE: LLY | Life Sciences | $1.35T | 3 | Insider SellingNov 3, 2026 |
| 13 | Johnson & JohnsonNYSE: JNJ | Life Sciences | $680B | 2 | Financial ResultsOct 21, 2026 |
| 14 | AbbVie Inc.NYSE: ABBV | Life Sciences | $521B | 5 | Insider SellingNov 12, 2026 |
| 23 | Merck & Co., Inc.NYSE: MRK | Life Sciences | $356B | 3 | Insider SellingNov 16, 2026 |
| 38 | Amgen IncNASDAQ: AMGN | Life Sciences | $250B | 3 | Financial ResultsNov 4, 2026 |
| 45 | Gilead Sciences, Inc.NASDAQ: GILD | Life Sciences | $208B | 12 | Insider SellingNov 16, 2026 |
| 53 | Abbott LaboratoriesNYSE: ABT | Life Sciences | $186B | 5 | Executive CompensationNov 16, 2026 |
| 65 | Pfizer IncNYSE: PFE | Life Sciences | $164B | 3 | Leadership ChangeNov 3, 2026 |
| 75 | Vertex Pharmaceuticals IncNASDAQ: VRTX | Life Sciences | $136B | 5 | Insider SellingNov 16, 2026 |
| 81 | Bristol Myers Squibb CoNYSE: BMY | Life Sciences | $129B | 3 | Insider SellingNov 6, 2026 |
| 133 | Moderna, Inc.NASDAQ: MRNA | Life Sciences | $87.1B | 8 | Loan & DebtNov 16, 2026 |
| 213 | Idexx Laboratories IncNASDAQ: IDXX | Life Sciences | $55.2B | 6 | Insider SellingNov 5, 2026 |
| 226 | Teva Pharmaceutical Industries LtdNYSE: TEVA | Life Sciences | $49.7B | 11 | Insider SellingNov 12, 2026 |
| 274 | Biogen Inc.NASDAQ: BIIB | Life Sciences | $37.2B | 2 | Financial ResultsOct 28, 2026 |
| 275 | Kenvue Inc.NYSE: KVUE | Life Sciences | $37.1B | 5 | Loan & DebtNov 4, 2026 |
| 286 | Revolution Medicines, Inc.NASDAQ: RVMD | Life Sciences | $36.1B | 14 | Insider SellingNov 13, 2026 |
| 294 | Zoetis Inc.NYSE: ZTS | Life Sciences | $34.3B | 4 | Financial ResultsNov 5, 2026 |
| 334 | Roivant Sciences Ltd.NASDAQ: ROIV | Life Sciences | $28B | 11 | Insider SellingNov 12, 2026 |
| 348 | Insmed IncNASDAQ: INSM | Life Sciences | $27B | 4 | Financial ResultsOct 29, 2026 |
| 364 | United Therapeutics CorpNASDAQ: UTHR | Life Sciences | $25B | 48 | Insider SellingNov 13, 2026 |
| 378 | Viatris IncNASDAQ: VTRS | Life Sciences | $23.8B | 3 | Financial ResultsNov 5, 2026 |
| 408 | BioNTech SENASDAQ: BNTX | Life Sciences | $21.4B | 8 | Insider SellingOct 9, 2026 |
| 410 | Alnylam Pharmaceuticals, Inc.NASDAQ: ALNY | Life Sciences | $21.4B | 6 | Insider BuyingNov 12, 2026 |
| 476 | Neurocrine Biosciences IncNASDAQ: NBIX | Life Sciences | $16.7B | 4 | Insider SellingNov 3, 2026 |
| 480 | Exelixis, Inc.NASDAQ: EXEL | Life Sciences | $16.4B | 2 | Financial ResultsOct 29, 2026 |
| 496 | Jazz Pharmaceuticals plcNASDAQ: JAZZ | Life Sciences | $15.4B | 12 | Insider SellingNov 10, 2026 |
| 505 | BridgeBio Pharma, Inc.NASDAQ: BBIO | Life Sciences | $15.1B | 6 | Insider SellingNov 3, 2026 |
| 553 | Elanco Animal Health IncNYSE: ELAN | Life Sciences | $13.2B | 3 | Financial ResultsNov 6, 2026 |
| 596 | BIO-TECHNE CorpNASDAQ: TECH | Life Sciences | $11.4B | 4 | Financial ResultsNov 6, 2026 |
| 601 | Biomarin Pharmaceutical IncNASDAQ: BMRN | Life Sciences | $11.2B | 7 | Financial ResultsNov 3, 2026 |
| 605 | Halozyme Therapeutics, Inc.NASDAQ: HALO | Life Sciences | $11B | 10 | Insider SellingNov 16, 2026 |
| 613 | Kymera Therapeutics, Inc.NASDAQ: KYMR | Life Sciences | $10.7B | 3 | Financial ResultsOct 29, 2026 |
| 619 | Repligen CorpNASDAQ: RGEN | Life Sciences | $10.4B | 7 | Loan & DebtNov 6, 2026 |
| 648 | Madrigal Pharmaceuticals, Inc.NASDAQ: MDGL | Life Sciences | $9.85B | 4 | Insider BuyingNov 6, 2026 |
| 655 | Vaxcyte, Inc.NASDAQ: PCVX | Life Sciences | $9.75B | 10 | Insider SellingNov 13, 2026 |
| 668 | Tg Therapeutics, Inc.NASDAQ: TGTX | Life Sciences | $9.49B | 2 | Financial ResultsNov 9, 2026 |
| 670 | Summit Therapeutics Inc.NASDAQ: SMMT | Life Sciences | $9.45B | 7 | Other 8-K FilingNov 16, 2026 |
| 672 | Spyre Therapeutics, Inc.NASDAQ: SYRE | Life Sciences | $9.44B | 6 | Financial ResultsNov 3, 2026 |
| 694 | Krystal Biotech, Inc.NASDAQ: KRYS | Life Sciences | $8.83B | 4 | Earnings CallNov 2, 2026 |
| 700 | Praxis Precision Medicines, Inc.NASDAQ: PRAX | Life Sciences | $8.67B | 3 | Investor PresentationNov 12, 2026 |
| 720 | Protagonist Therapeutics, IncNASDAQ: PTGX | Life Sciences | $8.15B | 3 | Financial ResultsNov 6, 2026 |
| 739 | Alkermes plc.NASDAQ: ALKS | Life Sciences | $7.82B | 7 | Court & Legal UpdateNov 12, 2026 |
| 753 | Corcept Therapeutics IncNASDAQ: CORT | Life Sciences | $7.58B | 13 | Insider SellingNov 13, 2026 |
| 754 | CG Oncology, Inc.NASDAQ: CGON | Life Sciences | $7.57B | 4 | Clinical Trial DataNov 16, 2026 |
| 759 | Rhythm Pharmaceuticals, Inc.NASDAQ: RYTM | Life Sciences | $7.45B | 2 | Financial ResultsNov 3, 2026 |
| 761 | Cytokinetics IncNASDAQ: CYTK | Life Sciences | $7.41B | 8 | Insider SellingNov 12, 2026 |
| 764 | Amneal Pharmaceuticals, Inc.NASDAQ: AMRX | Life Sciences | $7.4B | 3 | Financial ResultsNov 9, 2026 |
| 779 | Axsome Therapeutics, Inc.NASDAQ: AXSM | Life Sciences | $7.21B | 2 | Financial ResultsNov 2, 2026 |
| 781 | Twist Bioscience CorpNASDAQ: TWST | Life Sciences | $7.16B | 17 | Financial ResultsNov 16, 2026 |
| 794 | Immunovant, Inc.NASDAQ: IMVT | Life Sciences | $6.89B | 8 | Insider SellingNov 12, 2026 |
| 802 | Oruka Therapeutics, Inc.NASDAQ: ORKA | Life Sciences | $6.73B | 12 | Insider SellingNov 16, 2026 |
| 806 | Lantheus Holdings, Inc.NASDAQ: LNTH | Life Sciences | $6.65B | 7 | DivestitureNov 10, 2026 |
| 810 | Kodiak Sciences Inc.NASDAQ: KOD | Life Sciences | $6.59B | 8 | Financial ResultsNov 12, 2026 |
| 840 | ImmunityBio, Inc.NASDAQ: IBRX | Life Sciences | $6.36B | 6 | Financial ResultsNov 9, 2026 |
| 849 | Arrowhead Pharmaceuticals, Inc.NASDAQ: ARWR | Life Sciences | $6.25B | 3 | Financial ResultsNov 12, 2026 |
| 869 | Ligand Pharmaceuticals IncNASDAQ: LGND | Life Sciences | $6.04B | 11 | Insider SellingNov 16, 2026 |
| 875 | Mirum Pharmaceuticals, Inc.NASDAQ: MIRM | Life Sciences | $5.98B | 9 | Insider SellingNov 13, 2026 |
| 921 | Scholar Rock Holding CorpNASDAQ: SRRK | Life Sciences | $5.43B | 5 | Financial ResultsNov 10, 2026 |
| 924 | Veradermics, IncNYSE: MANE | Life Sciences | $5.4B | 6 | Insider SellingNov 13, 2026 |
| 934 | Erasca, Inc.NASDAQ: ERAS | Life Sciences | $5.3B | 3 | Financial ResultsNov 12, 2026 |
| 958 | PTC Therapeutics, Inc.NASDAQ: PTCT | Life Sciences | $5.09B | 10 | Stock BuybackNov 3, 2026 |
| 964 | Liquidia CorpNASDAQ: LQDA | Life Sciences | $5.08B | 16 | Financial ResultsNov 10, 2026 |
| 967 | Dianthus Therapeutics, Inc.NASDAQ: DNTH | Life Sciences | $5.04B | 4 | Insider SellingNov 12, 2026 |
| 990 | Edgewise Therapeutics, Inc.NASDAQ: EWTX | Life Sciences | $4.78B | 3 | Insider SellingNov 10, 2026 |
| 992 | Cogent Biosciences, Inc.NASDAQ: COGT | Life Sciences | $4.77B | 2 | Financial ResultsNov 5, 2026 |
| 995 | Travere Therapeutics, Inc.NASDAQ: TVTX | Life Sciences | $4.77B | 4 | Earnings CallNov 3, 2026 |
| 1010 | Ionis Pharmaceuticals IncNASDAQ: IONS | Life Sciences | $4.66B | 7 | Insider BuyingNov 13, 2026 |
| 1027 | Adaptive Biotechnologies CorpNASDAQ: ADPT | Life Sciences | $4.51B | 17 | Insider SellingNov 13, 2026 |
| 1080 | Definium Therapeutics, Inc.NASDAQ: DFTX | Life Sciences | $4.13B | 9 | Earnings CallNov 9, 2026 |
| 1087 | Tango Therapeutics, Inc.NASDAQ: TNGX | Life Sciences | $4.1B | 8 | Insider SellingNov 13, 2026 |
| 1097 | Structure Therapeutics Inc.NASDAQ: GPCR | Life Sciences | $3.99B | 2 | Financial ResultsNov 9, 2026 |
| 1102 | Crispr Therapeutics AGNASDAQ: CRSP | Life Sciences | $3.92B | 9 | Financial ResultsNov 2, 2026 |
| 1111 | Tarsus Pharmaceuticals, Inc.NASDAQ: TARS | Life Sciences | $3.88B | 3 | Financial ResultsNov 3, 2026 |
| 1115 | Xenon Pharmaceuticals Inc.NASDAQ: XENE | Life Sciences | $3.86B | 4 | Financial ResultsNov 9, 2026 |
| 1119 | Relay Therapeutics, Inc.NASDAQ: RLAY | Life Sciences | $3.82B | 7 | Financial ResultsNov 4, 2026 |
| 1130 | Silence Therapeutics plcNASDAQ: SLN | Life Sciences | $3.69B | 3 | Financial ResultsNov 13, 2026 |
| 1137 | Organon & Co.NYSE: OGN | Life Sciences | $3.65B | 2 | M&A DealOct 30, 2026 |
| 1139 | AbCellera Biologics Inc.NASDAQ: ABCL | Life Sciences | $3.63B | 4 | Insider BuyingNov 13, 2026 |
| 1148 | Amylyx Pharmaceuticals, Inc.NASDAQ: AMLX | Life Sciences | $3.57B | 10 | Insider SellingNov 12, 2026 |
| 1161 | Enliven Therapeutics, Inc.NASDAQ: ELVN | Life Sciences | $3.5B | 8 | Financial ResultsNov 5, 2026 |
| 1166 | Iovance Biotherapeutics, Inc.NASDAQ: IOVA | Life Sciences | $3.49B | 7 | Investor PresentationNov 5, 2026 |
| 1167 | Disc Medicine, Inc.NASDAQ: IRON | Life Sciences | $3.49B | 6 | Insider SellingNov 12, 2026 |
| 1176 | Arcutis Biotherapeutics, Inc.NASDAQ: ARQT | Life Sciences | $3.43B | 8 | Insider SellingNov 4, 2026 |
| 1181 | Viking Therapeutics, Inc.NASDAQ: VKTX | Life Sciences | $3.42B | 5 | Earnings CallNov 16, 2026 |
| 1187 | Indivior Pharmaceuticals, Inc.NASDAQ: SUPN | Life Sciences | $3.4B | 7 | Loan & DebtNov 3, 2026 |
| 1190 | Viridian Therapeutics, Inc.\DENASDAQ: VRDN | Life Sciences | $3.38B | 4 | Clinical Trial DataNov 9, 2026 |
| 1207 | DBV Technologies S.A.NASDAQ: DBVT | Life Sciences | $3.23B | 3 | Financial ResultsOct 28, 2026 |
| 1209 | Acadia Pharmaceuticals IncNASDAQ: ACAD | Life Sciences | $3.23B | 7 | Financial ResultsNov 5, 2026 |
| 1227 | Bausch Health Companies Inc.NYSE: BHC | Life Sciences | $3.15B | 2 | Financial ResultsOct 29, 2026 |
| 1230 | Dyne Therapeutics, Inc.NASDAQ: DYN | Life Sciences | $3.13B | 5 | Insider SellingNov 16, 2026 |
| 1246 | Xeris Biopharma Holdings, Inc.NASDAQ: XERS | Life Sciences | $3.05B | 12 | Insider SellingNov 6, 2026 |
| 1262 | Adma Biologics, Inc.NASDAQ: ADMA | Life Sciences | $2.99B | 5 | Insider SellingNov 16, 2026 |
| 1273 | Ideaya Biosciences, Inc.NASDAQ: IDYA | Life Sciences | $2.94B | 3 | Financial ResultsNov 3, 2026 |
| 1274 | Vericel CorpNASDAQ: VCEL | Life Sciences | $2.93B | 9 | Insider SellingNov 12, 2026 |
| 1279 | Denali Therapeutics Inc.NASDAQ: DNLI | Life Sciences | $2.9B | 2 | Financial ResultsNov 3, 2026 |
| 1315 | Xencor IncNASDAQ: XNCR | Life Sciences | $2.66B | 4 | Insider SellingNov 12, 2026 |
| 1322 | MBX Biosciences, Inc.NASDAQ: MBX | Life Sciences | $2.64B | 5 | Insider SellingNov 12, 2026 |
| 1358 | Arcus Biosciences, Inc.NYSE: RCUS | Life Sciences | $2.43B | 5 | Financial ResultsNov 4, 2026 |
| 1371 | Neogen CorpNASDAQ: NEOG | Life Sciences | $2.38B | 5 | Insider SellingNov 4, 2026 |
| 1374 | NewAmsterdam Pharma Co N.V.NASDAQ: NAMS | Life Sciences | $2.33B | 5 | Financial ResultsNov 4, 2026 |